用户名： 密   码：
注册 | 忘记密码？
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
专利信息
查询条件 展开筛选条件
  • [专利权人] 包含 'NOVARTIS AG [CH]'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页123456下页尾页 共 196 条记录, 当前第1/20页。
公开号 公开日 申请号 申请日
1. IL195425A 2014/1/30 IL20080195425 2008/11/20
专利标题：Galenical formulations of aliskiren and hydrochlorothiazide 法律状态
专利权人：NOVARTIS AG [CH];
2. WO2014011284A1 2014/1/16 WO2013US36273 2013/4/12
专利标题：METHOD OF TREATING GASTROINTESTINAL STROMAL TUMORS 法律状态
The present invention relates to a method of treating gastrointestinal stromal tumors (GIST), especially GIST, which is progressing after imatinib therapy or after imatinib and sunitinib therapy, using a combination comprising (a) a c-kit inhibitor and (b) a dual KIT inhibitor and FGFR inhibitor or FGFR inhibitor.

3. IL164837A 2013/12/31 IL20040164837 2004/10/25
专利标题：Pharmaceutical compositions comprising aliskiren, amlodipine and hydrochlorothiazide and kit comprising the same 法律状态
专利权人：NOVARTIS AG [CH];
4. IL153428A 2013/12/31 IL20020153428 2002/12/12
专利标题：Solid valsartan pharmaceutical compositions 法律状态
专利权人：NOVARTIS AG [CH];
5. KR20130141712A 2013/12/26 KR20137031543 2006/11/23
专利标题：F, G, H, I AND K CRYSTAL FORMS OF IMATINIB MESYLATE 法律状态
专利权人：NOVARTIS AG [CH];
6. KR20130140909A 2013/12/24 KR20137031544 2006/11/23
专利标题：F, G, H, I AND K CRYSTAL FORMS OF IMATINIB MESYLATE 法律状态
专利权人：NOVARTIS AG [CH];
7. KR20130139863A 2013/12/23 KR20137005256 2011/8/1
专利标题：HIGHLY CRYSTALLINE VALSARTAN 法律状态
专利权人：NOVARTIS AG [CH];
8. KR20130137721A 2013/12/17 KR20137031545 2006/11/23
专利标题：F, G, H, I AND K CRYSTAL FORMS OF IMATINIB MESYLATE 法律状态
专利权人：NOVARTIS AG [CH];
9. WO2013184621A1 2013/12/12 WO2013US43989 2013/6/4
专利标题：COMBINATION OF A 17 -ALPHA -HYDROXYLASE (C17, 20 - LYASE) INHIBITOR AND A SPECIFIC PI-3K INHIBITOR FOR TREATING A TUMOR DISEASE 法律状态
The present invention relates to a combination which comprises (a) a phosphatidylinositol 3-kinase inhibitor selected from the group consisting of a compound of formula (I) or a compound of formula (II), or pharmaceutically acceptable salt thereof, (b) a 17alpha-Hydroxylase/ C17,20-lyase inhibitor (CYP17 inhibitor), specifically abiraterone acetate and 1-(2-Chloro-pyridin-4-yl)-3-(4-methyl-pyridin-3-yl)-imidazolidin-2-one or pharmaceutically acceptable salt thereof, for simultaneous, separate or...

10. HK1133818A1 2013/12/6 HK20090110531 2009/11/11
专利标题：SOLID DOSAGE FORMS OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE AND METHOD OF MAKING THE SAME 法律状态
专利权人：NOVARTIS AG [CH];

首页123456下页尾页 共 196 条记录, 当前第1/20页。

下载范围

下载第 到 条记录。

下载内容

题录信息 专利全文